Gross Domestic Product (GDP) and productivity of schizophrenia trials: an ecological study

<p>Abstract</p> <p>Background</p> <p>The 5000 randomised controlled trials (RCTs) in the Cochrane Schizophrenia Group's database affords an opportunity to research for variables related to the differences between nations of their output of schizophrenia trials.<...

Full description

Bibliographic Details
Main Authors: Fenton Mark, El-sayeh Hany, Bartsch Stephanie, Gessler Ursula, Moll Carina, Adams Clive
Format: Article
Language:English
Published: BMC 2003-12-01
Series:BMC Psychiatry
Online Access:http://www.biomedcentral.com/1471-244X/3/18
_version_ 1830447844294656000
author Fenton Mark
El-sayeh Hany
Bartsch Stephanie
Gessler Ursula
Moll Carina
Adams Clive
author_facet Fenton Mark
El-sayeh Hany
Bartsch Stephanie
Gessler Ursula
Moll Carina
Adams Clive
author_sort Fenton Mark
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The 5000 randomised controlled trials (RCTs) in the Cochrane Schizophrenia Group's database affords an opportunity to research for variables related to the differences between nations of their output of schizophrenia trials.</p> <p>Methods</p> <p>Ecological study – investigating the relationship between four economic/demographic variables and number of schizophrenia RCTs per country. The variable with closest correlation was used to predict the expected number of studies.</p> <p>Results</p> <p>GDP closely correlated with schizophrenia trial output, with 76% of the total variation about the Y explained by the regression line (r = 0.87, 95% CI 0.79 to 0.92, r2 = 0.76). Many countries have a strong tradition of schizophrenia trials, exceeding their predicted output. All nations with no identified trial output had GDPs that predicted zero trial activity. Several nations with relatively small GDPs are, nevertheless, highly productive of trials. Some wealthy countries seem either not to have produced the expected number of randomised trials or not to have disseminated them to the English-speaking world.</p> <p>Conclusions</p> <p>This hypothesis-generating study could not investigate causal relationships, but suggests, that for those seeking all relevant studies, expending effort searching the scientific literature of Germany, Italy, France, Brazil and Japan may be a good investment.</p>
first_indexed 2024-12-21T07:29:32Z
format Article
id doaj.art-6ac445bbd2ac4667bf3a4ebc94cdb3db
institution Directory Open Access Journal
issn 1471-244X
language English
last_indexed 2024-12-21T07:29:32Z
publishDate 2003-12-01
publisher BMC
record_format Article
series BMC Psychiatry
spelling doaj.art-6ac445bbd2ac4667bf3a4ebc94cdb3db2022-12-21T19:11:36ZengBMCBMC Psychiatry1471-244X2003-12-01311810.1186/1471-244X-3-18Gross Domestic Product (GDP) and productivity of schizophrenia trials: an ecological studyFenton MarkEl-sayeh HanyBartsch StephanieGessler UrsulaMoll CarinaAdams Clive<p>Abstract</p> <p>Background</p> <p>The 5000 randomised controlled trials (RCTs) in the Cochrane Schizophrenia Group's database affords an opportunity to research for variables related to the differences between nations of their output of schizophrenia trials.</p> <p>Methods</p> <p>Ecological study – investigating the relationship between four economic/demographic variables and number of schizophrenia RCTs per country. The variable with closest correlation was used to predict the expected number of studies.</p> <p>Results</p> <p>GDP closely correlated with schizophrenia trial output, with 76% of the total variation about the Y explained by the regression line (r = 0.87, 95% CI 0.79 to 0.92, r2 = 0.76). Many countries have a strong tradition of schizophrenia trials, exceeding their predicted output. All nations with no identified trial output had GDPs that predicted zero trial activity. Several nations with relatively small GDPs are, nevertheless, highly productive of trials. Some wealthy countries seem either not to have produced the expected number of randomised trials or not to have disseminated them to the English-speaking world.</p> <p>Conclusions</p> <p>This hypothesis-generating study could not investigate causal relationships, but suggests, that for those seeking all relevant studies, expending effort searching the scientific literature of Germany, Italy, France, Brazil and Japan may be a good investment.</p>http://www.biomedcentral.com/1471-244X/3/18
spellingShingle Fenton Mark
El-sayeh Hany
Bartsch Stephanie
Gessler Ursula
Moll Carina
Adams Clive
Gross Domestic Product (GDP) and productivity of schizophrenia trials: an ecological study
BMC Psychiatry
title Gross Domestic Product (GDP) and productivity of schizophrenia trials: an ecological study
title_full Gross Domestic Product (GDP) and productivity of schizophrenia trials: an ecological study
title_fullStr Gross Domestic Product (GDP) and productivity of schizophrenia trials: an ecological study
title_full_unstemmed Gross Domestic Product (GDP) and productivity of schizophrenia trials: an ecological study
title_short Gross Domestic Product (GDP) and productivity of schizophrenia trials: an ecological study
title_sort gross domestic product gdp and productivity of schizophrenia trials an ecological study
url http://www.biomedcentral.com/1471-244X/3/18
work_keys_str_mv AT fentonmark grossdomesticproductgdpandproductivityofschizophreniatrialsanecologicalstudy
AT elsayehhany grossdomesticproductgdpandproductivityofschizophreniatrialsanecologicalstudy
AT bartschstephanie grossdomesticproductgdpandproductivityofschizophreniatrialsanecologicalstudy
AT gesslerursula grossdomesticproductgdpandproductivityofschizophreniatrialsanecologicalstudy
AT mollcarina grossdomesticproductgdpandproductivityofschizophreniatrialsanecologicalstudy
AT adamsclive grossdomesticproductgdpandproductivityofschizophreniatrialsanecologicalstudy